Invivo therapeutics holdings corp. (NVIV)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Operating expenses:
Research and development

1,051

1,317

1,459

1,716

1,110

1,579

928

1,026

1,398

1,560

2,928

3,211

3,384

3,900

3,294

2,795

2,568

2,777

2,432

2,546

2,303

1,595

2,385

3,051

3,242

3,708

3,021

2,591

1,213

2,753

1,374

1,307

940

1,057

1,016

1,392

636

324

468

General and administrative

1,377

1,422

1,273

1,532

1,668

1,431

1,185

1,786

3,434

3,122

3,388

3,715

3,285

2,932

2,584

2,991

2,999

2,481

3,437

3,214

3,208

2,249

1,800

1,688

1,829

1,967

2,386

2,481

1,638

-

-

-

-

-

-

-

764

424

326

General and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,466

1,447

1,520

-

1,196

1,135

-

-

-

Total operating expenses

2,428

2,739

2,732

3,248

2,778

3,010

2,113

2,812

4,832

4,682

6,316

6,926

6,669

6,832

5,878

5,786

5,567

5,258

5,869

5,760

5,511

3,844

4,185

4,739

5,071

5,675

5,407

5,072

2,851

4,722

2,840

2,755

2,460

2,517

2,213

2,527

1,400

748

794

Operating loss

-2,428

-2,739

-2,732

-3,248

-2,778

-3,010

-2,113

-2,812

-4,832

-4,682

-6,316

-6,926

-6,669

-6,832

-5,878

-5,786

-5,567

-5,258

-5,869

-5,760

-5,511

-3,844

-4,185

-4,739

-5,071

-5,675

-5,407

-5,072

-2,851

-4,722

-2,840

-2,755

-2,460

-2,517

-2,213

-2,527

-1,400

-748

-794

Other income / (expense):
Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

47

50

36

54

55

2

2

1

1

2

1

1

2

4

6

3

7

13

12

2

-1

4

2

2

0

0

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

31

32

29

63

74

32

32

34

33

35

35

33

34

34

33

29

43

12

10

5

2

0

8

1

-

176

(Decrease) increase in the fair value of the warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

765

-

-

0

-

-

-

-

-

-

-

-

Interest income

14

32

51

72

99

84

71

33

18

-

25

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-36

-

Interest income / (expense), net

-

-

-

-

-

-

-

-

-

-

-

32

37

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

-

-

2

32

-

-

834

26

42

-

-

-

-

1,397

-318

602

-1,056

525

3,561

-4,683

-10,319

-4,540

2,972

1,093

-32

-32

-30

-9,214

-10,475

-3,993

10,869

4,955

5,610

-

5,280

1,157

-

-

-

Derivatives loss

-

-

-

-

-

765

-1,967

-10,186

-12

-3

-3,059

554

241

1,381

-336

595

-1,047

544

3,591

-4,653

-10,286

-4,508

3,005

1,127

0

0

0

-8,422

-10,449

-3,956

10,869

4,954

5,613

-32,625

5,275

1,162

121

-51

-

Other income

-

-

-

-

44

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,623

-

-2,308

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income / (expense), net

14

-633

53

104

143

485

-1,062

-10,127

48

18

-3,034

586

278

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

122

-88

-176

Net loss

-2,414

-3,372

-2,679

-3,144

-2,635

-2,525

-3,175

-12,939

-4,784

-4,664

-9,350

-6,340

-6,391

-

-

-5,184

-

-

-

-10,443

-15,830

-

-1,213

-3,646

-5,103

-5,707

-5,437

-14,286

-13,326

-8,715

8,028

2,200

3,149

-35,147

3,067

-1,370

-1,277

-836

-970

Net loss per share, basic and diluted (in dollars per share)

-2.47

-26.16

-0.29

-0.34

-8.49

-129.57

-0.42

-7.48

-3.34

-3.40

-6.99

-4.92

-4.98

-0.17

-0.19

-0.16

-0.24

-0.14

-0.09

-0.39

-0.64

-

-0.05

-

-

-

-

-

-0.20

-

-

-

-

-

-

-

-

-

-0.03

Weighted average number of common shares outstanding, basic and diluted (In Shares)

976

-17,592

9,311

9,311

310

-10,059

7,562

1,729

1,432

1,363

1,337

1,287

1,283

32,054

31,968

31,907

28,171

-

27,010

26,508

-

-

-

-

-

-

-

-

66,043

-

-

-

-

-

-

-

-

-

-

Net loss

-2,414

-3,372

-2,679

-3,144

-2,635

-2,525

-3,175

-12,939

-4,784

-4,664

-9,350

-6,340

-6,391

-

-

-5,184

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,623

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized gain (loss) on marketable securities

-

-

-

-

-

-

-

-

-

-

-

1

-2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-

-

-

-

-

-

-

-

-

-4,663

-9,350

-6,339

-6,393

-

-

-5,184

-6,623

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share, basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.17

-0.28

-

-0.07

-0.20

-

-0.13

0.12

0.03

0.05

-0.68

0.06

-0.03

-0.02

-0.03

-

Net loss per share, diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.17

-0.28

-

-0.07

-0.20

-

-0.13

0.11

0.03

0.05

-0.68

0.06

-0.03

-0.02

-0.03

-

Weighted average number of common shares outstanding, basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24,909

-

23,364

21,821

18,540

-

78,603

72,389

-

65,688

65,109

64,105

58,004

52,352

51,889

51,676

51,660

31,147

-

Weighted average number of common shares outstanding, diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21,821

18,540

-

78,603

72,389

-

70,232

74,157

74,279

69,008

49,971

54,269

51,676

51,660

31,147

-

Weighted average number of common shares outstanding, basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30,675